Ronald Stoller, MD

Medical Oncologist

Conditions Treated

Laryngeal Cancer Lung Cancer Testicular Mesothelioma

Bio & Insurance Information

Dr. Ronald Stoller got his medical degree from Harvard Medical School in 1971 and completed his residency program at Peter Bent Brigham Hospital. He is specialized in oncology and board certified in internal medicine and medical oncology. Dr. Stoller has been in practice for more than 20 years and is affiliated with Magee Womens Hospital Of UPMC and UPMC Presbyterian.


Education & Training

Harvard Medical School Graduated in 1971

Medical School

Peter Bent Brigham Hospital Completed in 1973

Residency

National Cancer Institute Completed in 1976

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Oncology

Hospitals & Clinics

UPMC Passavant

Languages: English/Spanish

(412) 367-6700

9100 Babcock Blvd

Pittsburgh, Pennsylvania 15237

Read More

Magee Womens Hospital of UPMC Pittsburgh

Languages: English/Spanish

(412) 641-1000

300 Halket St

Pittsburgh, Pennsylvania 15213

Read More

UPMC Mercy

Languages: English/Spanish

(412) 232-8111

1400 Locust St

Pittsburgh, Pennsylvania 15219

Read More

UPMC Presbyterian Shadyside

Languages: English/Spanish

(412) 647–2345

200 Lothrop Street

Pittsburgh, Pennsylvania 15213-2536

Read More

UPMC Shadyside

Languages: English/Spanish

(412) 623-2121

5230 Centre Ave

Pittsburgh, Pennsylvania 15232

Read More

Publications

Dr. Ronald Stoller has contributed to 3 publications.

Pharmacokinetic Study of Pegylated Liposomal Ckd-602 (s-ckd602) in Patients with Advanced Malignancies

Zamboni WC1, Strychor S, Maruca L, Ramalingam S, Zamboni BA, Wu H, Friedland DM, Edwards RP, Stoller RG, Belani CP, Ramanathan RK.

See more >>

Phase I and Pharmacokinetic Study of Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Ramalingam SS1, Parise RA, Ramanathan RK, Lagattuta TF, Musguire LA, Stoller RG, Potter DM, Argiris AE, Zwiebel JA, Egorin MJ, Belani CP

See more >>

Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers

Ramanathan RK1, Egorin MJ, Eiseman JL, Ramalingam S, Friedland D, Agarwala SS, Ivy SP, Potter DM, Chatta G, Zuhowski EG, Stoller RG, Naret C, Guo J, Belani CP.

See more >>

Memberships

American Society of Clinical Oncology

Eastern Cooperative Oncology Group